home / stock / apls / apls articles

APLS Articles, Apellis Pharmaceuticals Inc. - From 03/19/24

Stock Information
Company Name: Apellis Pharmaceuticals Inc.
Stock Symbol: APLS
Market: NASDAQ
Menu
APLS APLS Quote APLS Short APLS News APLS Articles APLS Message Board
Get APLS Alerts

News, Short Squeeze, Breakout and More Instantly...
Investigation Alert: Cummins, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital - Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below | Benzinga

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and...
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor | Benzinga

WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that leading retina specialist Ph...

Investigation Alert Driven Brands Holdings, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below | Benzinga

SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and ...

ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results | Benzinga

Generated $397 million in full year 2023 revenues, including $275 million for SYFOVRE® (pegcetacoplan injection) and $91 million for EMPAVEL...

Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years | Benzinga

Apellis Pharmaceuticals (NASDAQ:APLS) has outperformed the market over the past 5 years by 23.37% on an annualized basis producing an average annua...

Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results | Benzinga

WALTHAM, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that the company will host a conf...
$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today | Benzinga

Apellis Pharmaceuticals (NASDAQ:APLS) has outperformed the market over the past 5 years by 24.05% on an annualized basis producing an average annua...

Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Previous 10 Next 10